State v. Thomas Treadway

COURT OF APPEALS
DECISION NOTICE
DATED AND FILED This opinion is subject to further editing. If
published, the official version will appear in
the bound volume of the Official Reports.
August 13, 2019
A party may file with the Supreme Court a
Sheila T. Reiff petition to review an adverse decision by the
Clerk of Court of Appeals Court of Appeals. See WIS. STAT. § 808.10
and RULE 809.62.

Appeal No. 2018AP1204 Cir. Ct. No. 1998CI17

STATE OF WISCONSIN IN COURT OF APPEALS
DISTRICT I

IN RE THE COMMITMENT OF THOMAS TREADWAY:

STATE OF WISCONSIN,

PETITIONER-RESPONDENT,

V.

THOMAS TREADWAY,

RESPONDENT-APPELLANT.

APPEAL from an order of the circuit court for Milwaukee County:
DENNIS R. CIMPL, Judge. Affirmed.

Before Brash, P.J., Kessler and Brennan, JJ.

Per curiam opinions may not be cited in any court of this state as precedent

or authority, except for the limited purposes specified in WIS. STAT. RULE 809.23(3).
No. 2018AP1204

¶1 PER CURIAM. Thomas Treadway appeals a circuit court order
permitting the State to medicate him without his consent. He claims that the State
presented insufficient evidence to support the order. We affirm.

Background

¶2 Treadway is a sexually violent person committed to the custody of
the Department of Health Services. See WIS. STAT. ch. 980 (2017-18).1 Since his
original commitment in 1999, the circuit court has entered a series of orders
subjecting him to the involuntary administration of medication. When the sixth
such order expired in 2015, DHS personnel did not immediately seek another
because Treadway was compliant with his medication regimen. In 2016, however,
he began intermittently refusing medication, and he correspondingly began to
exhibit increasing paranoia and violent behavior. In January 2018, Dr. Hugh
Johnston, Treadway’s treating physician at Sand Ridge Secure Treatment Center,
filed a petition to permit medicating and treating Treadway without his consent,
alleging that Treadway was not competent to refuse the medication and treatment
that he required. Attached to the petition was a report dated January 11, 2018,
signed by Johnston and by a second treatment provider, Dr. Donald Stonefeld.

¶3 The petition and attached report reflect that Treadway is mentally ill
and intellectually disabled. He carries diagnoses of: (1) Schizophrenia,
continuous (formerly categorized as paranoid schizophrenia); (2) Intellectual
Disability, mild; and (3) Other Specified Personality Disorder, with antisocial
features. He has a full scale IQ of 64, which is in the “extremely low range.” He

1
All references to the Wisconsin Statutes are to the 2017-18 version unless otherwise
noted.

2
No. 2018AP1204

requires psychotropic medication to combat his paranoia and control his violent
behavior, but as of the date of the report he was refusing medication with
increasing frequency.

¶4 The report documented that on November 20, 2017, Johnston
entered a psychiatric progress note stating that he had met with Treadway and
explained the risks, benefits, side effects, and alternatives to his prescribed
medications. Treadway, however, was incapable of applying that information
because he did not believe he was mentally ill. Further, the report reflected that
Johnston had “many conversations” with Treadway in the preceding months about
the advantages and disadvantages of medication, but “consistent with
[Treadway’s] cognitive disability,” he was unable to understand the explanations.
Then, in a meeting with Johnston on December 26, 2017, Treadway
“emphatically” refused medication and would not discuss the matter.

¶5 Johnston and Stonefeld explained in their report that Treadway was
becoming “intensely paranoid,” and the report included descriptions of
Treadway’s violent episodes and threats to harm staff members during December
2017. Additionally, the report reflected that Treadway’s paranoia “extends to the
medications themselves and fosters continued medication refusal.” Johnston and
Stonefeld concluded that the refusal to take medication led to Treadway’s
increasing hostility and “resulted in a vicious cycle.” Therefore, they requested
that the court permit involuntary medication and treatment.

¶6 The circuit court conducted a hearing on January 26, 2018.
Stonefeld testified that he was a psychiatrist with more than forty years of
experience, and he authenticated the January 11, 2018 report, which the circuit
court admitted as an exhibit. Stonefeld went on to describe Treadway’s diagnoses,

3
No. 2018AP1204

the violence and hostility occasioned by Treadway’s acute paranoia, and
Treadway’s need for medication. Stonefeld further testified that he met with
Treadway two weeks before the hearing and tried to engage him in a discussion
about his medication but Treadway was unable to apply the information to his
situation because he did not believe he had a mental illness.

¶7 Treadway also testified. He said that he “d[id]n’t have anything
against taking the medication. As a matter of fact, [he] feel[s] a lot better taking
the medication.” He went on to describe an incident during which police
restrained him in connection with a medical appointment, and he suggested that
this incident led him to refuse medication.

¶8 Additionally, Treadway offered commentary during the proceeding.
He interrupted Stonefeld’s testimony to assert that he was “not schizophrenic,”
and, after completing his own testimony, he added that he was not bothered by the
side effects of his prescribed medication because he received additional medicine
to address those side effects.

¶9 The circuit court ruled from the bench, finding first that Stonefeld
was credible. Based on his testimony and the report he prepared, the circuit court
found that Treadway was mentally ill, specifically, that he suffered from
schizophrenia; that he was cognitively disabled; and that he posed a risk of harm
to himself and others unless he was medicated. The circuit court went on to find
that Treadway was substantially incapable of applying an understanding of the
information he received about medication to his particular mental illness and that
he could not make an informed choice about whether to accept or refuse
psychotropic medication or treatment. Accordingly, the circuit court concluded
that Treadway was incompetent to refuse medication and signed an order that he

4
No. 2018AP1204

was subject to the involuntary administration of medication. He appeals,
challenging the sufficiency of the evidence.

Discussion

¶10 When the government seeks to involuntarily medicate a person, it
“bears the burden of proving [the person] incompetent to refuse medication by
clear and convincing evidence.” See Winnebago Cty. v. Christopher S., 2016 WI
1, ¶49, 366 Wis. 2d 1, 878 N.W.2d 109 (citation omitted; bracketed language
amended). On review, this court “will not disturb the circuit court’s factual
findings unless they are clearly erroneous” and “we accept reasonable inferences
from the facts available to the circuit court.” Id., ¶50 (citation omitted). Whether
the facts satisfy the burden of proof is a question of law that we review de novo.
See id.

¶11 The parties agree that because Treadway is committed to the custody
of DHS pursuant to WIS. STAT. ch. 980, he is a patient “entitled to the patients’
rights set forth in WIS. STAT. ch. 51.” See State v. Anthony D.B., 2000 WI 94,
¶13, 237 Wis. 2d 1, 614 N.W.2d 435. A patient’s competence to refuse
medication is determined under WIS. STAT. § 51.61(1)(g)4. The statute provides,
in pertinent part:

[A]n individual is not competent to refuse medication or
treatment if, because of mental illness, developmental
disability, alcoholism or drug dependence, and after the
advantages and disadvantages of and alternatives to
accepting the particular medication or treatment have been
explained to the individual[:]

....

b. The individual is substantially incapable of applying an
understanding of the advantages, disadvantages and
alternatives to his or her mental illness, developmental
disability, alcoholism or drug dependence in order to make

5
No. 2018AP1204

an informed choice as to whether to accept or refuse
medication or treatment.

Id., § 51.61(1)(g)4.b.2

¶12 On appeal, Treadway first complains that the State failed to satisfy
its statutory obligation to prove that he received an explanation of the “advantages,
disadvantages and alternatives to” psychotropic medication. See id. Specifically,
he asserts that “it is not clear when Dr. Johnston ... provided the statutorily
[required] explanation” and that the record does not include testimony about the
specifics of the explanations Treadway received. We reject these arguments.

¶13 The January 11, 2018 report signed by both Johnston and Stonefeld
explicitly states that Johnston documented a discussion with Treadway on
November 20, 2017, approximately two months before the hearing. The report
memorializes that Johnston “enumerated risks, benefits, side effects, and
alternatives related to various medications.” Further, the report memorializes that
Johnston and Treadway had many similar conversations during the months
preceding the hearing.

¶14 Additionally, Stonefeld testified that he met with Treadway on
January 12, 2018. Stonefeld said that he attempted at that time to explain the

2
WISCONSIN STAT. § 51.61(1)(g)4., includes an additional way to prove an individual is
not competent to refuse medication, namely, by showing that the individual “is incapable of
expressing an understanding of the advantages and disadvantages of accepting medication or
treatment and the alternatives.” See § 51.61(1)(g)4.a. The supreme court has observed that this
can be a “difficult standard,” depending on the circumstances. See Outagamie Cty. v. Melanie
L., 2013 WI 67, ¶54, 349 Wis. 2d 148, 833 N.W.2d 607. In this appeal, the State maintains that it
satisfied the burden of proof under both § 51.61(1)(g)4.a. and § 51.61(1)(g)4.b. The circuit court,
however, entered findings and conclusions reflecting its determination that the State satisfied the
latter provision. Because we agree with the circuit court, we do not consider whether the State
also satisfied § 51.61(1)(g)4.a. See State v. Hughes, 2011 WI App 87, ¶14, 334 Wis. 2d 445, 799
N.W.2d 504 (we decide cases on narrowest possible grounds).

6
No. 2018AP1204

benefits of treatment but Treadway responded that he would take medication only
if he had a mental illness, and he denied that he was mentally ill.

¶15 Treadway testified on his own behalf and provided additional
evidence that he had received the required information. He indicated that he was
aware of the advantages of medication, telling the circuit court that he “feel[s] a
lot better taking medication.” He also indicated his awareness of the
disadvantages, acknowledging that the medication causes side effects but stating
that they do not bother him because a supplemental medication controls them. In
short, the January 11, 2018 report, coupled with the testimony, showed that
Treadway received information about and was familiar with the advantages,
disadvantages, and alternatives to psychotropic medication. Indeed, the evidence
was uncontested.3

¶16 Where the undisputed evidence mirrors the statutory language and
establishes that the patient received information about the advantages,
disadvantages, and alternatives to medication, the evidence satisfies the statutory
standard. See Christopher S., 366 Wis. 2d 1, ¶¶54-56. That is the case here.
3
Treadway complains that “there was no documentation” of his discussion with
Stonefeld about the risks and benefits of taking medication, “as required by Melanie L.” This
assertion mischaracterizes both the record and Melanie L. Stonefeld, who testified by telephone,
explained that he was “reading from [his] report” as he described Treadway’s response to an
explanation about the use of psychotropic medications. Stonefeld also explicitly acknowledged
that he, along with Johnston, signed the January 11, 2018 report detailing the discussions with
Treadway that are memorialized in progress notes dated, e.g., November 20, 2017, and December
26, 2017. Regardless, Melanie L. does not mandate documentation of a patient’s discussion with
treatment providers. Rather, Melanie L. states that “[m]edical professionals and other
professionals should document the timing and frequency of their explanations so that, if
necessary, they have documentary evidence to help establish this element in court.” Id., 349
Wis. 2d 148, ¶67. Here, the record shows that the doctors involved in Treadway’s treatment
memorialized their interactions with Treadway sufficiently to establish in court the fact and
frequency of the explanations that he received. Nothing further is required. See Winnebago Cty.
v. Christopher S., 2016 WI 1, ¶56, 366 Wis. 2d 1, 878 N.W.2d 109.

7
No. 2018AP1204

Accordingly, Treadway fails to show that the evidence was insufficient to prove
he received information as required about the advantages, disadvantages, and
alternatives to medication.

¶17 Treadway next asserts that the evidence was insufficient to prove he
was “substantially incapable of applying an understanding” of the information he
received about the medication to his mental illness. See WIS. STAT.
§ 51.61(1)(g)4.b. We disagree.

¶18 In Outagamie County v. Melanie L., 2013 WI 67, 349 Wis. 2d 148,
833 N.W.2d 607, the supreme court discussed the government’s burden to prove
under WIS. STAT. § 51.61(1)(g)4.b. that a person is “substantially incapable” of
applying necessary information and emphasized that “substantially incapable” is a
“less rigorous standard” than “incapable.” See Melanie L., 349 Wis. 2d 148,
¶¶69-70; see also id., ¶54 (standard codified in § 51.61(1)(g)4.b. is “somewhat
relaxed”). The court went on to hold that the statutory standard requires a
showing that “to a considerable degree, a person lacks the ability or capacity ... to
make a connection between an expressed understanding of the benefits and risks
of medication and the person’s own mental illness.” See Melanie L., 349 Wis. 2d
148, ¶¶70-71(emphasis omitted).

¶19 Here, the January 11, 2018 report reflected that Johnston had “many
conversations” with Treadway about risks, benefits, and alternatives to
medications, but Treadway’s responses demonstrated “that his understanding is
too limited to provide a rational basis for making consent decisions.” The report
stated that “this is consistent with [Treadway’s] cognitive disability,” specifically
his very low IQ of 64. At the hearing, Stonefeld elaborated on why Treadway was
not only unable to understand the necessary information regarding advantages,

8
No. 2018AP1204

disadvantages, and alternatives to medication but was also incapable of applying
that information to his particular mental illness. Specifically, Stonefeld testified
that the “fundamental error” characterizing a schizophrenic patient’s thinking is
the certainty that the patient is not ill: “[i]n the middle of the acute phase or even
moderately acute phase there is no acceptance of the idea of mental illness.”
Stonefeld also described Treadway’s most recent statements that he was not
mentally ill and therefore would not take the medications prescribed for him.

¶20 In Melanie L., the supreme court acknowledged the potentiality
“that if a person cannot recognize that he ... has a mental illness, logically the
person cannot establish a connection between his ... expressed understanding of
the benefits and risks of medication and the person’s own illness.” Id., ¶72.; see
also Winnebago Cty. v. M.O.S., No. 2015AP2619, unpublished slip op. ¶8 (WI
App June 15, 2016) (noting that, under Melanie L., lack of insight and denial of
mental illness can show that a person is unable to apply an understanding of
psychotropic treatment to the person’s condition).4 This is such a case. The
record shows that Treadway suffers from schizophrenia and a significant cognitive
impairment. He does not recognize that he is mentally ill, however, and his
untreated illness and his intellectual limitations prevent him from understanding
and applying the information he receives about medication to the facts of his
illness. Again, the record contains no contrary evidence.

¶21 Treadway next asserts that the State failed to present evidence that
he held “patently false beliefs regarding the medication.” We cannot agree. The

4
Pursuant to WIS. STAT. RULE 809.23(3)(b)., unpublished authored opinions issued on
or after July 1, 2009, may be cited for their persuasive value.

9
No. 2018AP1204

January 11, 2018 report expressly stated that Treadway was experiencing
increasingly paranoid delusions, and his escalating paranoia “extends to the
medications themselves and fosters continued medication refusal.”

¶22 Finally, Treadway argues that the State failed to offer testimony “as
to why Treadway’s negative opinion of medications should be disregarded other
than Treadway’s mental illness and deteriorating behavior.” We reject the
suggestion that WIS. STAT. § 51.61(1)(g)4.b. required the State to offer such
testimony. The statute gives a patient the right to choose not to take medication
only if the patient is competent to make that choice. See Melanie L., 349 Wis. 2d
148, ¶78. Accordingly, “the court’s determination should not turn on the person’s
choice to refuse to take medication; it should turn on the person’s ability to
process and apply the information available to the person’s own condition before
making that choice.” See id. The evidence here therefore appropriately focused
on Treadway’s mental illness, his intellectual capacity, and the effect of those
factors on his ability to make a connection between the risks and benefits of
medication and his diagnosis of schizophrenia.

¶23 In sum, the record shows that the State presented clear and
convincing evidence to prove the disputed components of WIS. STAT.
§ 51.61(1)(g)4.b. Because we are satisfied that the State satisfied its burden of
proof, we affirm the order of the circuit court.

By the Court.—Order affirmed.

This opinion will not be published. See WIS. STAT.
RULE 809.23(1)(b)5.

10